1. Assessing Unwanted Variations in Rheumatology Clinic Previsit Rooming. Issue 3 (April 2019) Authors: Ramly, Edmond; Stroik, Brad; Lauver, Diane R.; Johnson, Heather M.; McBride, Patrick; Steffen Lewicki, Kristin; Arnason, Jon; Bartels, Christie M. Journal: Journal of clinical rheumatology Issue: Volume 25:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy. (4th December 2021) Authors: Trottier, Caitlin; Larsen, Christian; Bindal, Poorva; Dodge, Laura E; Elavalakanar, Pavania; Knudsen, Elisabeth; Kim, Sirwoo; Logan, Emma; Urman, Arielle R; Frigault, Matthew; Fishman, Jay A; Fishman, Jay A; Arnason, Jon; Alonso, Carolyn D Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy. (4th December 2021) Authors: Trottier, Caitlin; Larsen, Christian; Bindal, Poorva; Dodge, Laura E; Elavalakanar, Pavania; Knudsen, Elisabeth; Kim, Sirwoo; Logan, Emma; Urman, Arielle R; Frigault, Matthew; Fishman, Jay A; Fishman, Jay A; Arnason, Jon; Alonso, Carolyn D Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. (20th January 2017) Authors: Bar‐Natan, Michal; Stroopinsky, Dina; Luptakova, Katarina; Coll, Maxwell D.; Apel, Arie; Rajabi, Hasan; Pyzer, Athalia R.; Palmer, Kristen; Reagan, Michaela R.; Nahas, Myrna R.; Karp Leaf, Rebecca; Jain, Salvia; Arnason, Jon; Ghobrial, Irene M.; Anderson, Kenneth C.; Kufe, Donald; Rosenblatt, Jac... Journal: British journal of haematology Issue: Volume 176:Number 6(2017) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial. Issue 10343 (18th June 2022) Authors: Kamdar, Manali; Solomon, Scott R; Arnason, Jon; Johnston, Patrick B; Glass, Bertram; Bachanova, Veronika; Ibrahimi, Sami; Mielke, Stephan; Mutsaers, Pim; Hernandez-Ilizaliturri, Francisco; Izutsu, Koji; Morschhauser, Franck; Lunning, Matthew; Maloney, David G; Crotta, Alessandro; Montheard, Sandr... Journal: Lancet Issue: Volume 399:Issue 10343(2022) Page Start: 2294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years. (5th November 2015) Authors: Schram, Alison M.; Comstock, Paige; Campo, Meghan; Gorovets, Daniel; Mullally, Ann; Bodio, Kelly; Arnason, Jon; Berliner, Nancy Journal: British journal of haematology Issue: Volume 172:Number 3(2016) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Complete responses to odronextamab in two patients with diffuse large B‐cell lymphoma refractory to chimeric antigen receptor T‐cell therapy. (27th July 2022) Authors: Weinstock, Matt; Elavalakanar, Pavania; Bright, Susan; Ambati, Srikanth R.; Brouwer‐Visser, Jurriaan; Pourpe, Stephane; Fiaschi, Nathalie; Jankovic, Vladimir; Thurston, Gavin; Deering, Raquel P.; Chaudhry, Aafia; Joyce, Robin; Arnason, Jon Journal: British journal of haematology Issue: Volume 199:Number 3(2022) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma. (October 2012) Authors: Arnason, Jon; Avigan, David Journal: Immunotherapy Issue: Volume 4:Number 10(2012:Oct.) Page Start: 1043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma. (October 2012) Authors: Arnason, Jon; Avigan, David Journal: Immunotherapy Issue: Volume 4:Number 10(2012:Oct.) Page Start: 1043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Issue 10254 (19th September 2020) Authors: Abramson, Jeremy S; Palomba, M Lia; Gordon, Leo I; Lunning, Matthew A; Wang, Michael; Arnason, Jon; Mehta, Amitkumar; Purev, Enkhtsetseg; Maloney, David G; Andreadis, Charalambos; Sehgal, Alison; Solomon, Scott R; Ghosh, Nilanjan; Albertson, Tina M; Garcia, Jacob; Kostic, Ana; Mallaney, Mary; Oga... Journal: Lancet Issue: Volume 396:Issue 10254(2020) Page Start: 839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗